{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:03:16Z","timestamp":1788386596983,"version":"build-2803163510"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","worldneurosurgery.org","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.wneu.2018.08.019","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T06:04:23Z","timestamp":1534745063000},"page":"366-373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Towards Molecular Classification of Meningioma: Evolving Treatment and Diagnostic Paradigms"],"prefix":"10.1016","volume":"119","author":[{"given":"Dustin T.","family":"Proctor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudheesh","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanju","family":"Lama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garnette R.","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2018.08.019_bib1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","article-title":"Epidemiology and etiology of meningioma","volume":"99","author":"Wiemels","year":"2010","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2018.08.019_bib2","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ncl.2016.06.014","article-title":"Epidemiology of brain tumors","volume":"34","author":"McNeill","year":"2016","journal-title":"Neurol Clin"},{"key":"10.1016\/j.wneu.2018.08.019_bib3","first-page":"665","article-title":"Incidence and clinicopathological features of meningioma","volume":"71","author":"Rohringer","year":"1989","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2018.08.019_bib4","first-page":"231","article-title":"The histopathological spectrum of human meningiomas","volume":"5","author":"Backer-Gr\u00f8ndahl","year":"2012","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.wneu.2018.08.019_bib5","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.wneu.2018.08.019_bib6","first-page":"51","article-title":"The recurrence of intracranial meningiomas after surgical treatment","volume":"58","author":"Adegbite","year":"1983","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2018.08.019_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.wneu.2017.03.009","article-title":"Clinical outcome, tumor recurrence, and causes of death: a long-term follow-up of surgically treated meningiomas","volume":"102","author":"de Almeida","year":"2017","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2018.08.019_bib8","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00000478-199505000-00001","article-title":"Clear cell meningioma. A clinicopathologic study of a potentially aggressive variant of meningioma","volume":"19","author":"Zorludemir","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.wneu.2018.08.019_bib9","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/PAS.0b013e318194c566","article-title":"Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation","volume":"33","author":"Sangoi","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.wneu.2018.08.019_bib10","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/neuonc\/nov247","article-title":"Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539","volume":"18","author":"Rogers","year":"2016","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2018.08.019_bib11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00401-016-1598-1","article-title":"Brain invasion in otherwise benign meningiomas does not predict tumor recurrence","volume":"132","author":"Baumgarten","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.wneu.2018.08.019_bib12","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1056\/NEJMoa070972","article-title":"Incidental findings on brain MRI in the general population","volume":"357","author":"Vernooij","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2018.08.019_bib13","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2340\/16501977-1795","article-title":"Cognitive and emotional problems in patients after cerebral meningioma surgery","volume":"46","author":"van der Vossen","year":"2014","journal-title":"J\u00a0Rehabil Med"},{"key":"10.1016\/j.wneu.2018.08.019_bib14","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s11060-014-1679-8","article-title":"Cognitive improvement in meningioma patients after surgery: clinical relevance of computerized testing","volume":"121","author":"Meskal","year":"2015","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2018.08.019_bib15","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S1470-2045(16)30321-7","article-title":"EANO guidelines for the diagnosis and treatment of meningiomas","volume":"17","author":"Goldbrunner","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.wneu.2018.08.019_bib16","doi-asserted-by":"crossref","first-page":"936","DOI":"10.4065\/73.10.936","article-title":"Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988","volume":"73","author":"Stafford","year":"1998","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.wneu.2018.08.019_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0090-3019(85)90180-6","article-title":"The growth rate of intracranial meningiomas and its relation to histology. An analysis of 43 patients","volume":"24","author":"J\u00e4\u00e4skel\u00e4inen","year":"1985","journal-title":"Surg Neurol"},{"key":"10.1016\/j.wneu.2018.08.019_bib18","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/neuonc\/not110","article-title":"The immune cell infiltrate populating meningiomas is composed of mature, antigen-experienced T and B cells","volume":"15","author":"Fang","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2018.08.019_bib26","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1126\/science.1233009","article-title":"Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO","volume":"339","author":"Clark","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.wneu.2018.08.019_bib27","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/ng.3651","article-title":"Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas","volume":"48","author":"Clark","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.wneu.2018.08.019_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ng.2526","article-title":"Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations","volume":"45","author":"Brastianos","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.wneu.2018.08.019_bib29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00401-013-1093-x","article-title":"Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations","volume":"125","author":"Reuss","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.wneu.2018.08.019_bib30","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.3892\/ol.2014.2042","article-title":"EGFR, PIK3CA, KRAS and BRAF mutations in meningiomas","volume":"7","author":"Bujko","year":"2014","journal-title":"Oncol Lett"},{"key":"10.1016\/j.wneu.2018.08.019_bib31","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00401-013-1187-5","article-title":"AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry","volume":"126","author":"Sahm","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.wneu.2018.08.019_bib32","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/neuonc\/nox018","article-title":"Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1\/2 activation and reduced time to tumor recurrence","volume":"19","author":"Yesil\u00f6z","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2018.08.019_bib33","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/neuonc\/nov316","article-title":"Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma","volume":"18","author":"Abedalthagafi","year":"2016","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2018.08.019_bib34","first-page":"438","article-title":"Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas","volume":"127","author":"Strickland","year":"2017","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2018.08.019_bib35","first-page":"345","article-title":"SMO mutation status defines a distinct and frequent molecular subgroup in olfactory groove meningiomas","volume":"19","author":"Boetto","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2018.08.019_bib36","doi-asserted-by":"crossref","first-page":"djv377","DOI":"10.1093\/jnci\/djv377","article-title":"TERT promoter mutations and risk of recurrence in meningioma","volume":"108","author":"Sahm","year":"2016","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.wneu.2018.08.019_bib37","doi-asserted-by":"crossref","first-page":"109228","DOI":"10.18632\/oncotarget.22650","article-title":"Intratumoral heterogeneity and","volume":"8","author":"Juratli","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.wneu.2018.08.019_bib38","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/neuonc\/nos129","article-title":"Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: clinical, radiological, and molecular features","volume":"14","author":"Goutagny","year":"2012","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2018.08.019_bib39","doi-asserted-by":"crossref","first-page":"14433","DOI":"10.1038\/ncomms14433","article-title":"Integrated genomic analyses of de novo pathways underlying atypical meningiomas","volume":"8","author":"Harmanc\u0131","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.wneu.2018.08.019_bib40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41525-017-0014-7","article-title":"Genomic landscape of high-grade meningiomas","volume":"2","author":"Bi","year":"2017","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.wneu.2018.08.019_bib41","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/hmg\/10.14.1519","article-title":"Functional analysis of neurofibromatosis 2 (NF2) missense mutations","volume":"10","author":"Gutmann","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.wneu.2018.08.019_bib42","first-page":"109","article-title":"Long-term natural history of neurofibromatosis type 2-associated intracranial tumors","volume":"117","author":"Dirks","year":"2012","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2018.08.019_bib43","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/path.4427","article-title":"Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas","volume":"234","author":"Smith","year":"2014","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.wneu.2018.08.019_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10048-011-0300-y","article-title":"Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri","volume":"13","author":"van den Munckhof","year":"2012","journal-title":"Neurogenetics"},{"key":"10.1016\/j.wneu.2018.08.019_bib45","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/jmg.2009.075721","article-title":"SMARCB1 mutations are not a common cause of multiple meningiomas","volume":"47","author":"Hadfield","year":"2010","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.wneu.2018.08.019_bib46","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/neuonc\/nox094","article-title":"Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas","volume":"19","author":"Shankar","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2018.08.019_bib47","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/neuonc\/nox094","article-title":"BAP1 mutations in high-grade meningioma: implications for patient care","volume":"19","author":"Shankar","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2018.08.019_bib48","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ajhg.2012.07.015","article-title":"Loss of SUFU function in familial multiple meningioma","volume":"91","author":"Aavikko","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.wneu.2018.08.019_bib49","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1038\/sj.onc.1202531","article-title":"NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas","volume":"18","author":"Leone","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.wneu.2018.08.019_bib50","doi-asserted-by":"crossref","first-page":"14719","DOI":"10.1073\/pnas.94.26.14719","article-title":"Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression","volume":"94","author":"Weber","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.wneu.2018.08.019_bib51","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0002-9440(10)61737-3","article-title":"Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas","volume":"159","author":"Bostr\u00f6m","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.wneu.2018.08.019_bib52","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1158\/1078-0432.CCR-10-0891","article-title":"Genomic profiling reveals alternative genetic pathways of meningioma malignant progression dependent on the underlying NF2 status","volume":"16","author":"Goutagny","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.wneu.2018.08.019_bib53","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","article-title":"DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis","volume":"18","author":"Sahm","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.wneu.2018.08.019_bib54","doi-asserted-by":"crossref","first-page":"e54114","DOI":"10.1371\/journal.pone.0054114","article-title":"DNA methylation in the malignant transformation of meningiomas","volume":"8","author":"Gao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.wneu.2018.08.019_bib55","first-page":"899","article-title":"Methylation markers of malignant potential in meningiomas","volume":"119","author":"Vengoechea","year":"2013","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2018.08.019_bib56","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/carcin\/bgr260","article-title":"Epigenetic subclassification of meningiomas based on genome-wide DNA methylation analyses","volume":"33","author":"Kishida","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.wneu.2018.08.019_bib57","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12974-015-0388-3","article-title":"Mast cells in meningiomas and brain inflammation","volume":"12","author":"Polyzoidis","year":"2015","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.wneu.2018.08.019_bib58","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.18632\/oncotarget.3082","article-title":"Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma","volume":"6","author":"Du","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.wneu.2018.08.019_bib59","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s11060-016-2256-0","article-title":"Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma","volume":"130","author":"Han","year":"2016","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2018.08.019_bib60","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.ajpath.2012.07.033","article-title":"Immunophenotypic identification and characterization of tumor cells and infiltrating cell populations in meningiomas","volume":"181","author":"Domingues","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.wneu.2018.08.019_bib61","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11060-010-0339-x","article-title":"Meningiomas and neurofibromatosis","volume":"99","author":"Goutagny","year":"2010","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2018.08.019_bib62","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/(SICI)1097-4547(19980201)51:3<403::AID-JNR13>3.0.CO;2-7","article-title":"Merlin differentially associates with the microtubule and actin cytoskeleton","volume":"51","author":"Xu","year":"1998","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1016\/j.wneu.2018.08.019_bib63","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/sj.onc.1201418","article-title":"Interdomain binding mediates tumor growth suppression by the NF2 gene product","volume":"15","author":"Sherman","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.wneu.2018.08.019_bib64","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/363515a0","article-title":"Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2","volume":"363","author":"Rouleau","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2018.08.019_bib65","doi-asserted-by":"crossref","first-page":"e52707","DOI":"10.1371\/journal.pone.0052707","article-title":"Analysis of gene expression profiling in meningioma: deregulated signaling pathways associated with meningioma and EGFL6 overexpression in benign meningioma tissue and serum","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.wneu.2018.08.019_bib66","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.addr.2010.11.001","article-title":"Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis","volume":"63","author":"Zhao","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.wneu.2018.08.019_bib67","first-page":"503","article-title":"Focal adhesion kinase and cancer","volume":"24","author":"Golubovskaya","year":"2009","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.wneu.2018.08.019_bib68","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ygyno.2014.04.044","article-title":"Analyses of merlin\/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer","volume":"134","author":"Shah","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.wneu.2018.08.019_bib69","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/ncomms3185","article-title":"Frequency of TERT promoter mutations in human cancers","volume":"4","author":"Vinagre","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.wneu.2018.08.019_bib70","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1407279","article-title":"Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors","volume":"372","author":"Eckel-Passow","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2018.08.019_bib71","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.1229259","article-title":"Highly recurrent TERT promoter mutations in human melanoma","volume":"339","author":"Huang","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.wneu.2018.08.019_bib72","doi-asserted-by":"crossref","first-page":"8712","DOI":"10.18632\/oncotarget.6007","article-title":"TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas","volume":"7","author":"Gao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.wneu.2018.08.019_bib73","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1016\/j.cellsig.2014.08.011","article-title":"TRAF-mediated modulation of NF-kB and JNK activation by TNFR2","volume":"26","author":"Cabal-Hierro","year":"2014","journal-title":"Cell Signal"},{"key":"10.1016\/j.wneu.2018.08.019_bib74","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/jcp.25676","article-title":"The emerging role of TRAF7 in tumor development","volume":"232","author":"Zotti","year":"2017","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.wneu.2018.08.019_bib75","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1001\/jamaoncol.2016.0891","article-title":"Landscape of phosphatidylinositol-3-kinase pathway alterations across 19 784 diverse solid tumors","volume":"2","author":"Millis","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.wneu.2018.08.019_bib76","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1073\/pnas.0701005104","article-title":"Rare cancer-specific mutations in PIK3CA show gain of function","volume":"104","author":"Gymnopoulos","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.wneu.2018.08.019_bib77","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1158\/0008-5472.CAN-12-1726","article-title":"PIK3CA mutation H1047R is associated with response to PI3K\/AKT\/mTOR signaling pathway inhibitors in early-phase clinical trials","volume":"73","author":"Janku","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.wneu.2018.08.019_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djw320","article-title":"Durable control of metastatic AKT1-mutant WHO grade 1 meningothelial meningioma by the AKT inhibitor, AZD5363","volume":"109","author":"Weller","year":"2017","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.wneu.2018.08.019_bib79","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1200\/JCO.2017.73.0143","article-title":"AKT inhibition in solid tumors with AKT1 mutations","volume":"35","author":"Hyman","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.wneu.2018.08.019_bib80","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nrm3598","article-title":"The mechanisms of Hedgehog signalling and its roles in development and disease","volume":"14","author":"Briscoe","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.wneu.2018.08.019_bib81","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1758834010366430","article-title":"Targeting the Hedgehog pathway in cancer","volume":"2","author":"Gupta","year":"2010","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.wneu.2018.08.019_bib82","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/jmg.35.6.450","article-title":"Genotype\/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations","volume":"35","author":"Evans","year":"1998","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.wneu.2018.08.019_bib83","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1399-0004.2009.01315.x","article-title":"Further genotype\u2013phenotype correlations in neurofibromatosis 2","volume":"77","author":"Selvanathan","year":"2010","journal-title":"Clin Genet"},{"key":"10.1016\/j.wneu.2018.08.019_bib84","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jmedgenet-2017-104519","article-title":"Genetic Severity Score predicts clinical phenotype in NF2","volume":"54","author":"Halliday","year":"2017","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.wneu.2018.08.019_bib85","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10014-016-0271-7","article-title":"Genetic landscape of meningioma","volume":"33","author":"Yuzawa","year":"2016","journal-title":"Brain Tumor Pathol"},{"key":"10.1016\/j.wneu.2018.08.019_bib86","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4419-9967-2_1","article-title":"DNA methyltransferases, DNA damage repair, and cancer","volume":"754","author":"Jin","year":"2013","journal-title":"Adv Exp Med Biol"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187887501831800X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187887501831800X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T00:30:02Z","timestamp":1604795402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187887501831800X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":79,"alternative-id":["S187887501831800X"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2018.08.019","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards Molecular Classification of Meningioma: Evolving Treatment and Diagnostic Paradigms","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2018.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}